期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重视对比剂肾病的防控 被引量：2

下载PDF
导出
摘要 自1954年Bartels等[1]报道了首例对比剂肾病（CIN）后,半个多世纪以来专家学者对其认识逐渐加深。CIN目前已是仅次于肾灌注不足和肾毒性药物引起的医院获得性急性肾损伤的第三大常见原因,占全部医院获得性急性肾损伤的11%[2]。
作者 程虹 高玉梅
机构地区 首都医科大学附属北京安贞医院
出处 《山东医药》 CAS 2012年第4期9-10,共2页 Shandong Medical Journal
关键词 对比剂肾病 获得性急性肾损伤 防控
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献11

  • 1Bartels ED, Brun GC, Gammeltoft A, et al. Acute anuria following intravenous pyelography in a patient with myelomatosis [ J ]. Acta Med Scand, 1954,150 (4) :297-302.
  • 2Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency [J]. Am J Kidney Dis, 2002,39(5) :930-936.
  • 3McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy [ J ]. Am J Cardiol, 2006,98(6A) :5K-13K.
  • 4Budano C, Levis M, D'Amico M, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes [ J ]. Am Heart J, 2011,161 (5) :963-971.
  • 5de Bie MK, van Rees JB, Herzog CA, et al. How to reduce the incidence of contrast induced acute kidney injury after cardiac invasive procedures, a review and practical recommendations [ J]. Curt Med Res Opin, 2011,27(7) :1347-1357.
  • 6Toprak O, Cirit M. Risk factors and therapy strategies for contrast- induced nephropathy [ J ]. Ren Fail, 2006,28 (5) :365-381.
  • 7Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. NGAL ( neutrophil gelatinase-associated lipocalin) and cystatin C : are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creati- nine [J]. Int J Cardiol, 2008,127(2) :290-291.
  • 8Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children [ J ]. Pediatr Nephrol, 2007,22 ( 12 ) :2089-2095.
  • 9王冬松,李文华,韩飞,张延斌,徐通达,朱红,李东野.用ROC曲线评价NGAL对冠脉诊疗术后对比剂肾病的早期诊断价值[J].中华全科医学,2011,9(10):1503-1504. 被引量：4
  • 10Caruso M, Balasus F, Incalcaterra E, et al. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized [J]. Intern Med, 2011,50(9) :983-989.

二级参考文献10

  • 1Mishra J, Morri K, Ma Q, et al. Amelioration of ischemic acute renal injuey by neutrophil gelatinase-associated lipocalin [ J ]. J Am Soc Nephrol,2004,15 ( 12 ) :3073-3082.
  • 2Mori K, Lee HT, Rapoport D, et al. Endoeytic delivery of lipoealin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury [ J ]. J Clin Invest,2005,115 ( 3 ) :610-621.
  • 3Ling W,Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography [J]. Nephron Clin Pract, 2008,108 ( 3 ) : 176-181.
  • 4Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophil gelatinase associated lipocalin and renal function after percutaneous coronary interventions[J]. Am J Nephrol,2006 ,26 :287-292.
  • 5Russel Hirsch, Catherine Dent, Holly Pfriem, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children [ J ]. Pediatric Nephrology ,2007,28:2089-2095.
  • 6Mehran R. Contrast-induced nephropathy remains a serious complication of PCI[ J ]. J Interv Cardiol,2007,20 ( 3 ) :236-240.
  • 7Stuart L. Goldstein. Pediatric acute kidney injury : it' s time for real progress[ J ]. Pediatr Nephrol,2006,21 ( 7 ) :891-895.
  • 8Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associatedlipocalin as a novel early urinary biomarker for ischemic renal injury[J]. J Am Soc Nephrol,2003,14(10) :2534-2543.
  • 9Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associatedlipocalin(NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet,2005,365 ( 9466 ) : 1231-1238.
  • 10Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil-gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children; a prosperctive cohort study [J]. Crit Care, 2007,11 (4) :R84.

共引文献3

同被引文献13

  • 1Krasuski RA, Beard BM, Geoghagan JD, et al. Optimal timing of hydra- tion to erase contrast-associated nephropathy:the OTHER CAN study[J]. J Invasive Cardiol, 2003,15 (12) : 699-702.
  • 2Kagan A, Sheikh-Hamad D. Contrast-induced kidney injury:focus on modifiable risk factors and prophylactic strategies [ J ]. Clin Cardiol, 2010,33 (2) :62-66.
  • 3Hardy J, Hambly B, Ko H, et al. Stimulation of mesangial cells by an- giotensin 1I and lipopolysaccharide crases expression of interleukin-18, but not IL-18 receptor [ J ]. Nephron Exp Nephrol, 2010,116 ( 4 ) : 63- 71.
  • 4Odutayo A, Cherney D. Cystatin C and acute changes in glomerular fil- tration rate [ J]. Clin Nephro1,2012,78 ( 1 ) :64-75.
  • 5Devarajan P. Biomarkers for the early detection of acute kidney injury [ J]. Curr Opifi Pediatr,2011,23 (2) : 194-200.
  • 6Yue Du, Michael Zappitelli, Asad Mian, et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center[ J]. Pedi- atric Nephrology,2011,26 (2) :267-274.
  • 7Tehrani S, laing C,Yellon DM, et al. Contrast-induced acute kidney in- jury following PCI [ J ]. Eur J Clin Invest, 2013,43 ( 5 ) :483-490.
  • 8Ling W,Zhao hui N,Ben H,et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography [ J ]. Nephron Clin Pratt ,2008,108 ( 3 ) : 176-181.
  • 9Bulent Gul CB, gullulu M, Oral B, et al. Urinary 1L-18:a marker of contrast-induced nephropathy following percutaneous coronary inter- vention? [J]. Clin Bioehem.2008.41 (7-8 ):544-547.
  • 10颜红兵,彭红玉.预防对比剂肾病的策略与进展[J].心血管病学进展,2009,30(5):765-768. 被引量：5

引证文献2

二级引证文献3

山东医药
2012年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部